APA

Parseghian C. M., Loree J. M., Morris V. K., Liu X., Clifton K. K., Napolitano S., Henry J. T., Pereira A. A., Vilar E., Johnson B., Kee B., Raghav K., Dasari A., Wu J., Garg N., Raymond V. M., Banks K. C., Talasaz A. A., Lanman R. B., Strickler J. H., Hong D. S., Corcoran R. B., Overman M. J. & Kopetz S. (20200304). Anti-EGFR-resistant clones decay exponentially after progression: implications for anti-EGFR re-challenge. : Annals of oncology : official journal of the European Society for Medical Oncology.

Chicago

Parseghian C M, Loree J M, Morris V K, Liu X, Clifton K K, Napolitano S, Henry J T, Pereira A A, Vilar E, Johnson B, Kee B, Raghav K, Dasari A, Wu J, Garg N, Raymond V M, Banks K C, Talasaz A A, Lanman R B, Strickler J H, Hong D S, Corcoran R B, Overman M J and Kopetz S. 20200304. Anti-EGFR-resistant clones decay exponentially after progression: implications for anti-EGFR re-challenge. : Annals of oncology : official journal of the European Society for Medical Oncology.

Harvard

Parseghian C. M., Loree J. M., Morris V. K., Liu X., Clifton K. K., Napolitano S., Henry J. T., Pereira A. A., Vilar E., Johnson B., Kee B., Raghav K., Dasari A., Wu J., Garg N., Raymond V. M., Banks K. C., Talasaz A. A., Lanman R. B., Strickler J. H., Hong D. S., Corcoran R. B., Overman M. J. and Kopetz S. (20200304). Anti-EGFR-resistant clones decay exponentially after progression: implications for anti-EGFR re-challenge. : Annals of oncology : official journal of the European Society for Medical Oncology.

MLA

Parseghian C M, Loree J M, Morris V K, Liu X, Clifton K K, Napolitano S, Henry J T, Pereira A A, Vilar E, Johnson B, Kee B, Raghav K, Dasari A, Wu J, Garg N, Raymond V M, Banks K C, Talasaz A A, Lanman R B, Strickler J H, Hong D S, Corcoran R B, Overman M J and Kopetz S. Anti-EGFR-resistant clones decay exponentially after progression: implications for anti-EGFR re-challenge. : Annals of oncology : official journal of the European Society for Medical Oncology. 20200304.